Related Experiment Video
Updated: May 12, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European
Ryan E Aylward1,2, Samantha Hayward3,4, Nicholas C Chesnaye5,6
1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Insights
This study links higher levels of specific proteins, including Receptor-type tyrosine-protein phosphatase S, to faster kidney function decline in older adults with advanced chronic kidney disease (CKD). These findings highlight fibrogenesis and complement pathways in CKD progression.
Area of Science:
- Proteomics
- Nephrology
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) and chronic kidney disease (CKD) share similar pathophysiological mechanisms.
- Investigating protein expression in advanced CKD can elucidate kidney function decline.
- Older adults with advanced CKD present a critical population for understanding disease progression.
Purpose of the Study:
- To investigate the associations between cardiometabolic protein expression and pathways with kidney function decline.
- To explore the mechanisms underlying CKD progression in older adults.
- To identify specific proteins and pathways linked to the rate of estimated glomerular filtration rate (eGFR) decline.
Main Methods:
- Utilized plasma proteomic panels (Olink cardiometabolic T96 and cardiovascular II T96) from the European Quality (EQUAL) Study.
- Analyzed longitudinal estimated glomerular filtration rate (eGFR) data from European adults aged over 65 with advanced CKD (eGFR <20 mL/min/1.73 m²).
- Employed generalized linear mixed-effects models to estimate protein-slope associations and pathway enrichment analysis for biological pathways.
Main Results:
- Higher expression of Receptor-type tyrosine-protein phosphatase S, Insulin-like growth factor binding protein 6, and Ficolin 2 were significantly associated with accelerated eGFR decline.
- A doubling of Receptor-type tyrosine-protein phosphatase S expression correlated with a -15.4% annual change in eGFR.
- Validated associations were found between specific proteins and the rate of kidney function loss across discovery and validation cohorts.
Conclusions:
- Elevated protein expression and pathways related to fibrogenesis and the complement cascade are associated with kidney function loss in advanced CKD.
- These findings suggest potential therapeutic targets for slowing CKD progression.
- Further research is needed to validate these findings and explore kidney cellular proteomic signatures.
Background:
Cardiovascular disease and chronic kidney disease (CKD) progression pathophysiology are similar. We investigated associations of cardiometabolic protein expression and pathways with kidney function decline in older adults with advanced CKD referred for nephrology assessment.
Methods:
Two plasma proteomic panels analysed at baseline (Olink® cardiometabolic T96 and cardiovascular II T96, Uppsala, Sweden) and longitudinal estimated glomerular filtration rate (eGFR) data from European adults aged >65 years with a single eGFR of <20 mL/min/1.73 m2 [European Quality (EQUAL) Study] were used to explore mechanisms of CKD progression. Protein-slope associations were estimated using generalized linear mixed-effects models and with a false-discovery rate P < .05 taken to validation to verify the effect size of the association. Proteins were further modularized into biological pathways using pathway enrichment analysis.
Results:
A discovery sub-cohort of 238 complete-case participants from Germany, the UK and Poland (median age 76 years, 41% female sex, median baseline eGFR 17.8 mL/min/1.73 m2) were included and 246 participants from Sweden formed the validation sub-cohort (median age 75 years, 28% female, median baseline eGFR 17.5 mL/min/1.73 m2). Of the 175 analysed proteins, higher expression levels of Receptor-type tyrosine-protein phosphatase S [-15.4% change in eGFR per year per doubling of protein expression; 95% confidence interval (CI) -23.5%, -7.6%], Insulin-like growth factor binding protein 6 (-7.9%; 95% CI -12.3%, -3.5%) and Ficolin 2 (-7.4%; 95% CI -12.0%, -2.8%) showed a validated association with eGFR decline.
Conclusions:
Higher expression levels of proteins and biological pathways involving fibrogenesis and the complement cascade were found to be associated with kidney function loss. However, study limitations and unavailability of concurrent kidney cellular proteomic signatures necessitate further study.
More Related Videos
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Hormonal Regulation
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Kidney Structure
mTOR Signaling and Cancer Progression
The mTOR pathway or the...